This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Search results
From Proteopedia
You searched for Cetuximab
There is no page with the exact title "Cetuximab". The search results for "Cetuximab" are displayed below. You can create a page titled Cetuximab (by clicking on the red link).
For more information about searching Proteopedia, see Help.
To exclude pages titled with 4-character PDB codes, use the checkbox "only Human created pages" at the bottom of this page.
Showing below up to 20 results starting with #1.
View (previous 20) (next 20) (20 | 50 | 100 | 250 | 500)
Article title matches
- Category:Cetuximab (40 bytes)
1: List of pages with the keyword Cetuximab - Category:Cetuximab resistance (51 bytes)
1: List of pages with the keyword Cetuximab resistance
Page text matches
- 4hjg (3,750 bytes)
12: ...has moderate affinity for the Fab, is specific to cetuximab (i.e., does not bind to human IgGs), and has no s... - 1yy9 (6,910 bytes)
2: ...ctor receptor in complex with the Fab fragment of cetuximab/Erbitux/IMC-C225==
26: ...oinhibited" or "tethered" inactive configuration. Cetuximab interacts exclusively with domain III of sEGFR, p...
28: ...bition of the epidermal growth factor receptor by cetuximab.,Li S, Schmitz KR, Jeffrey PD, Wiltzius JJ, Kussi... - 4gw5 (1,773 bytes)
2: ==cQYN meditope - Cetuximab Fab== - 1yy8 (3,816 bytes)
2: ... of the Fab fragment from the monoclonal antibody cetuximab/Erbitux/IMC-C225==
21: ...oinhibited" or "tethered" inactive configuration. Cetuximab interacts exclusively with domain III of sEGFR, p...
23: ...bition of the epidermal growth factor receptor by cetuximab.,Li S, Schmitz KR, Jeffrey PD, Wiltzius JJ, Kussi... - 4hkz (3,903 bytes)
13: ...has moderate affinity for the Fab, is specific to cetuximab (i.e., does not bind to human IgGs), and has no s... - 3b2u (4,263 bytes)
24: ...GFR. We compare this to our previous study of the cetuximab/EGFR interaction. Fab11F8 interacts with a remark... - 3b2v (4,128 bytes)
24: ...GFR. We compare this to our previous study of the cetuximab/EGFR interaction. Fab11F8 interacts with a remark... - 3c08 (3,782 bytes)
22: ... ligand-binding region on domain III and from the cetuximab/Erbitux epitope. Matuzumab blocks ligand-induced ... - 3c09 (6,376 bytes)
26: ... ligand-binding region on domain III and from the cetuximab/Erbitux epitope. Matuzumab blocks ligand-induced ... - 4ioi (3,729 bytes)
12: ...has moderate affinity for the Fab, is specific to cetuximab (i.e., does not bind to human IgGs), and has no s... - 3gkw (4,507 bytes)
22: ...verlaps with both the surface patch recognized by Cetuximab (another anti-EGFR antibody) and the binding site... - Monoclonal Antibody (16,417 bytes)
54: ...dy binding to targets. They were able to increase cetuximab (Erbitux) affinity 10 fold and comparable improve... - 4krl (5,958 bytes)
16: ...nd binding to EGFR in a manner similar to that of cetuximab. EgA1 and 9G8 bind an epitope near the EGFR domai... - 4krm (5,942 bytes)
16: ...nd binding to EGFR in a manner similar to that of cetuximab. EgA1 and 9G8 bind an epitope near the EGFR domai... - 4krn (3,284 bytes)
12: ...nd binding to EGFR in a manner similar to that of cetuximab. EgA1 and 9G8 bind an epitope near the EGFR domai... - 4kro (5,892 bytes)
16: ...nd binding to EGFR in a manner similar to that of cetuximab. EgA1 and 9G8 bind an epitope near the EGFR domai... - 4krp (5,891 bytes)
16: ...nd binding to EGFR in a manner similar to that of cetuximab. EgA1 and 9G8 bind an epitope near the EGFR domai... - 4m7j (4,456 bytes)
12: ...e therapeutic antibody Cetuximab; however, unlike Cetuximab, one of the unliganded structures in S25-26 shows... - 4m7z (4,137 bytes)
11: ...e therapeutic antibody Cetuximab; however, unlike Cetuximab, one of the unliganded structures in S25-26 shows... - 4m93 (4,112 bytes)
12: ...e therapeutic antibody Cetuximab; however, unlike Cetuximab, one of the unliganded structures in S25-26 shows...
View (previous 20) (next 20) (20 | 50 | 100 | 250 | 500)
You may also try
